Comparative in vitro activity of Sch 29,482, a new oral penem, against Neisseria gonorrhoeae.
AUTOR(ES)
Khan, M Y
RESUMO
The in vitro activity of Sch 29,482, a new oral beta-lactam antimicrobial agent, was compared with those of norfloxacin, rosoxacin, ampicillin, erythromycin, and tetracycline against 142 Neisseria gonorrhoeae strains. Sch 29,482 was as active as norfloxacin and rosoxacin. Its activity was greater than the other three antimicrobial agents. It inhibited 90% of the isolates, regardless of beta-lactamase activity, at a concentration of less than or equal to 0.06 micrograms/ml.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=184673Documentos Relacionados
- Evaluation of Sch 29,482 in the eradication of Neisseria meningitidis from nasopharyngeal carriers.
- In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae.
- Comparative in-vitro activity of selected new beta-lactam antimicrobials against Neisseria gonorrhoeae.
- Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
- Comparative in vitro activity of cefmenoxime, cefotaxime, cefuroxime, cefoxitin, and penicillin against Neisseria gonorrhoeae.
